According to EasyCapital, Wei Yuan Synthetic Biotechnology (Beijing) Co., Ltd. announced the completion of over 0.3 billion yuan Series A financing. The lead investor in this round of financing is Jingguo Investment Fund, followed by Beijing Medical and Health Industry Investment Fund, Shen Chuangtou, Hebei Industrial Investment Golden Wealth Synthetic Equity Investment Fund. Existing shareholders Shunxi Fund and Henan Investment Group Huirong Fund continue to increase their investments, and EasyCapital serves as the exclusive financial advisor. The funds raised in this round of financing will be mainly used to promote the industrialization of multiple products and the construction of the Wei Yuan Synthetic Beidaihe production base.